Scinovex
review Open AccessTop 1% cited

Reactive Oxygen Species in the Tumor Microenvironment: An Overview

Cancers · 2019 · Vol. 11(8) · pp. 1191–1191
Frank WeinbergNithya RamnathDeepak Nagrath

Abstract

Reactive oxygen species (ROS) are important signaling molecules in cancer. The level of ROS will determine physiological effects. While high levels of ROS can cause damage to tissues and cell death, low levels of ROS can have a proliferative effect. ROS are produced by tumor cells but also cellular components that make up the tumor microenvironment (TME). In this review, we discuss the mechanisms by which ROS can affect the TME with particular emphasis on tumor-infiltrating leukocytes. Greater insight into ROS biology in this setting may allow for therapeutic manipulation of ROS levels in order to remodel the tumor microenvironment and increase anti-tumor activity.

Immune cells in cancerCancer, Hypoxia, and MetabolismFerroptosis and cancer prognosisReactive oxygen speciesTumor microenvironmentCell biologyCancer researchCell signalingChemistryTumor cellsBiologySignal transduction

Funding

  • National Institutes of Health
  • National Cancer Institute
Citations
469
FWCI
19.50
field-weighted impact
References
160
Percentile
100%
vs. same field & year
Citations per year
Cited by
Flavonoids as Anticancer Agents
Nutrients · 2020 · 1,205 citations
Related articles
Reactive oxygen species in abiotic stress signaling
Physiologia Plantarum · 2009 · 523 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.